Reactive oxygen species (ROS) reduce the expression of BRAK/CXCL14 in human head and neck squamous cell carcinoma cells

By Maehata Yojiro   Ozawa Shigeyuki   Kobayashi Kyo   Kato Yasumasa   Yoshino Fumihiko   Miyamoto Chihiro   Izukuri Kazuhito   Kubota Eiro   Hata Ryu-Ichiro   Lee Masaichi-Chang-Il  

Free Radical Research, Vol. 44, Iss. 8, 2010-08 ,pp. : 913-924

Informa Healthcare

Access to resources Recommend Favorite

Epidermal growth factor receptor (EGFR) mutations as biomarker for head and neck squamous cell carcinomas (HNSCC)

By Nagalakshmi K.   Jamil Kaiser   Pingali Usharani   Reddy M. Vishnuvardhan   Attili Suresh S. V.  

Biomarkers, Vol. 19, Iss. 3, 2014-05 ,pp. : 198-206

Informa Healthcare

Access to resources Recommend Favorite

Prognostic value of transforming growth factor beta 1 [TGF-β1] and matrix metalloproteinase 9 [MMP-9] in oral squamous cell carcinoma

By Elahi Maryam   Rakhshan Vahid   Ghasemian Nasim Taghavi   Moshref Mohamad  

Biomarkers, Vol. 17, Iss. 1, 2012-02 ,pp. : 21-27

Informa Healthcare

Access to resources Recommend Favorite

Targeting head and neck squamous cell carcinoma using a novel fusion toxin-diphtheria toxin/HN-1

By Potala Sirisha   Verma Rama  

Molecular Biology Reports, Vol. 38, Iss. 2, 2011-02 ,pp. : 1389-1397

Springer Publishing Company

Access to resources Recommend Favorite

MET and RON Receptor Tyrosine Kinases: Novel Therapeutic Targets in Squamous Cell Carcinoma of the Head and Neck

By  

Current Enzyme Inhibition, Vol. 3, Iss. 1, 2007-02 ,pp. : 1-12

Bentham Science Publishers

Access to resources Recommend Favorite